Variant report
Variant | esv3519315 |
---|---|
Chromosome Location | chr1:104668122-104670754 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AMY1C-2 | chr1:104668179-104668541 | XLOC_000326 |
2 | lnc-AMY1C-2 | chr1:104668178-104668541 | NONHSAT004905 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548106065 | chr1:104668209-104668210 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs943964 | chr1:104668220-104668221 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs533882138 | chr1:104668242-104668243 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs558726269 | chr1:104668253-104668254 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs570559135 | chr1:104668274-104668275 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs537869753 | chr1:104668309-104668310 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs115145474 | chr1:104668320-104668321 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs575049047 | chr1:104668362-104668363 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs542482395 | chr1:104668390-104668391 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs138712052 | chr1:104668402-104668403 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs572562968 | chr1:104668460-104668461 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs115037923 | chr1:104668475-104668476 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs149389145 | chr1:104668483-104668484 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs370400994 | chr1:104668493-104668494 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs181216934 | chr1:104668501-104668502 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs538963452 | chr1:104668581-104668582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543425899 | chr1:104668589-104668590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374893742 | chr1:104668646-104668647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114005236 | chr1:104668678-104668679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529947460 | chr1:104668692-104668693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147477066 | chr1:104668705-104668706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557678759 | chr1:104668707-104668708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184971596 | chr1:104668802-104668803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527530621 | chr1:104668812-104668813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552378847 | chr1:104668860-104668861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77545683 | chr1:104668870-104668871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116045227 | chr1:104668874-104668875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555910519 | chr1:104668899-104668900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375815036 | chr1:104668900-104668901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535786608 | chr1:104669028-104669029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554480781 | chr1:104669060-104669061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17019073 | chr1:104669145-104669146 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs17476187 | chr1:104669154-104669155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557892367 | chr1:104669275-104669276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113139986 | chr1:104669276-104669277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71655848 | chr1:104669285-104669286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576133127 | chr1:104669375-104669376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543485071 | chr1:104669390-104669391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138142041 | chr1:104669397-104669398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189519831 | chr1:104669447-104669448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113460109 | chr1:104669471-104669472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56175747 | chr1:104669474-104669475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541044432 | chr1:104669492-104669493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532990437 | chr1:104669503-104669504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527573391 | chr1:104669515-104669516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111875953 | chr1:104669625-104669626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111264518 | chr1:104669632-104669633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28438397 | chr1:104669650-104669651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374359933 | chr1:104669693-104669694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs55816437 | chr1:104669811-104669812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104667800-104669000 | Enhancers | Primary hematopoietic stem cells | blood |
2 | chr1:104667800-104669000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr1:104667800-104669200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr1:104668000-104668400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr1:104668000-104668400 | Enhancers | Placenta Amnion | Placenta Amnion |
6 | chr1:104668000-104669400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr1:104668200-104668800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr1:104668400-104674800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr1:104668600-104669000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr1:104669400-104678400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |